Causative drug detection by drug-induced lymphocyte stimulation test in drug-induced linear IgA bullous dermatosis

2016 ◽  
Vol 175 (5) ◽  
pp. 1106-1108 ◽  
Author(s):  
E. Tomida ◽  
Y. Kato ◽  
H. Ozawa ◽  
H. Hasegawa ◽  
N. Ishii ◽  
...  
1994 ◽  
Vol 17 (7) ◽  
pp. 921-926 ◽  
Author(s):  
Tomoaki YOSHIMURA ◽  
Chikako KURITA ◽  
Futoshi YAMAZAKI ◽  
Satoshi NAKANO ◽  
Hiroichi NAGAI

Kanzo ◽  
2001 ◽  
Vol 42 (9) ◽  
pp. 448-454 ◽  
Author(s):  
Masaaki WATANABE ◽  
Akitaka SHIBUYA ◽  
Akihiko SATOMICHI ◽  
Kouji ONO ◽  
Takeshi TSUCHIHASHI ◽  
...  

2020 ◽  
Vol 40 (4) ◽  
pp. 419-421
Author(s):  
Saori Minato ◽  
Haruhisa Miyazawa ◽  
Taisuke Kitano ◽  
Mitsutoshi Shindo ◽  
Kiyonori Ito ◽  
...  

A 49-year-old woman developed eosinophilic peritonitis 2 months after starting continuous ambulatory peritoneal dialysis because of congenital right kidney hypoplasia and chronic glomerulonephritis. This was shown to have been induced by sucroferric oxyhydroxide, an iron-based phosphate binder, using a drug-induced lymphocyte stimulation test. Her eosinophilic peritonitis was improved after stopping the administration of sucroferric oxyhydroxide without providing any immunosuppressive agents.


2017 ◽  
Vol 24 (7) ◽  
pp. 540-543 ◽  
Author(s):  
Satoru Mitsuboshi ◽  
Hiromi Kozakai ◽  
Hitoshi Yamada ◽  
Kazuhiko Nagai ◽  
Tomoyasu Furukawa ◽  
...  

Chemotherapy-induced interstitial lung disease in colorectal cancer patients is rare but represents a life-threatening adverse reaction. We report here a case of interstitial lung disease following chemotherapy for metastatic colorectal cancer and the interesting results of the drug-induced lymphocyte stimulation test and leukocyte migration test. After chemotherapy with oxaliplatin plus infusional 5-fluorouracil and leucovorin (FOLFOX) plus bevacizumab followed by irinotecan plus infusional 5-fluorouracil and leucovorin (FOLFIRI), the patient was hospitalized with fever and chills. Laboratory data showed neutropenia and eosinophilia. Computed tomography revealed ground-glass opacities in both lungs; therefore, we diagnosed chemotherapy-induced interstitial lung disease. Steroid therapy was effective. We suspected irinotecan to be the etiological drug for interstitial lung disease in this patient because interstitial lung disease developed after switching the regimen from FOLFOX to FOLFIRI. However, drug-induced lymphocyte stimulation test and leukocyte migration test results were positive for only leucovorin and negative for irinotecan and 5-fluorouracil. This is the first case to show positive results on the drug-induced lymphocyte stimulation test and leukocyte migration test for only leucovorin and negative results for antineoplastic drugs. Our findings suggest that all drugs included in chemotherapy regimens have the potential to induce interstitial lung disease, and if rechallenge chemotherapy is considered, the drug-induced lymphocyte stimulation test and leukocyte migration test are expected to be useful for determining the drug that needs to be excluded.


Sign in / Sign up

Export Citation Format

Share Document